1.
Giorgetti G. P103 | Partial inhibition of NAMPT restores metabolic vulnerability and synergizes with anti-myeloma agents in multiple myeloma: <a href="https://haematologica.org/search/search?query=G.+Giorgetti">G. Giorgetti</a><sup>1</sup>, <a href="https://haematologica.org/search/search?query=I.+Traverso">I. Traverso</a><sup>2</sup>, <a href="https://haematologica.org/search/search?query=D.+Soncini">D. Soncini</a><sup>1|2</sup>, <a href="https://haematologica.org/search/search?query=F.+Lai">F. Lai</a><sup>1</sup>, <a href="https://haematologica.org/search/search?query=B.+Antonioli">B. Antonioli</a><sup>2</sup>, <a href="https://haematologica.org/search/search?query=M.+Garibotto">M. Garibotto</a><sup>1</sup>, <a href="https://haematologica.org/search/search?query=F.+Guolo">F. Guolo</a><sup>1|2</sup>, <a href="https://haematologica.org/search/search?query=A.+Cagnetta">A. Cagnetta</a><sup>1</sup>, <a href="https://haematologica.org/search/search?query=D.+Fenoglio">D. Fenoglio</a><sup>1|3</sup>, <a href="https://haematologica.org/search/search?query=S.+Ravera">S. Ravera</a><sup>1|4</sup>, <a href="https://haematologica.org/search/search?query=E.+Marcenaro">E. Marcenaro</a><sup>1|4</sup>, <a href="https://haematologica.org/search/search?query=M.+Greppi">M. Greppi</a><sup>4</sup>, <a href="https://haematologica.org/search/search?query=S.+Bruzzone">S. Bruzzone</a><sup>1|4</sup>, <a href="https://haematologica.org/search/search?query=A.+Benzi">A. Benzi</a><sup>4</sup>, <a href="https://haematologica.org/search/search?query=W.+Min">W. Min</a><sup>5</sup>, <a href="https://haematologica.org/search/search?query=M.+Shelle">M. Shelle</a><sup>5</sup>, <a href="https://haematologica.org/search/search?query=R.M.+Lemoli">R.M. Lemoli</a><sup>1|2</sup>, <a href="https://haematologica.org/search/search?query=M.+Cea">M. Cea</a><sup>1|2</sup> | <i><sup>1</sup>IRCCS Ospedale Policlinico San Martino; <sup>2</sup>Clinic of Hematology, Department of Internal Medicine and Medical Specialties DiMI, University of Genoa; <sup>3</sup>Centre of Excellence for Biomedical Research, Department of Internal Medicine, University of Genoa; <sup>4</sup>Department of Experimental Medicine DIMES, University of Genoa; <sup>5</sup>Remedy Plan Therapeutics</i&gt;. Haematologica;111(s1):; https://doi.org/10.3324/haematol.2026.s1.160.